Genital warts are caused by human papillomavirus (HPV) types 6 and 11 in over 90% of cases — non-cancerous but cosmetically and psychologically distressing, with high transmission rate to partners. Treatment options include topical immune-response modifiers (imiquimod), cytotoxic agents (podophyllotoxin), and clinic-based ablation (cryotherapy, electrocautery, laser, surgical excision).
Raktáron lévő opció. Imiquimod 5% cream is the most-used topical immunotherapy for external genital warts. Apply to wart areas at bedtime three times weekly (alternate nights) for up to 16 weeks; wash off in the morning (6–10 hours after application). Stocked as Imiquad krém. Side-effects: local erythema, erosion, itching, burning — these are part of the immune response and signal effective treatment. Recurrence is possible; partners should be examined and treated as needed. Podophyllotoxin solution (an alternative cytotoxic agent for self-application) is not currently in our routine stock.
Akut rövid távú álmatlanság (időeltolódás, gyász, átmeneti stressz) — melatonin 1–3 mg 30–60 perccel lefekvés előtt 1–2 hétig. Késleltetett alvásfázis-zavar (különösen serdülőknél és műszakos dolgozóknál) — melatonin 0,5–1 mg, 4–6 órával a kívánt alváskezdés előtt. Krónikus álmatlanság (több mint 3 hónap) — első vonalban CBT-I; gyógyszeres lehetőségek kiválasztott esetekben orvosi felügyelet mellett. External anogenital warts in non-pregnant adults → imiquimod 5% cream three nights per week, up to 16 weeks. Pregnancy → cryotherapy or trichloroacetic acid in clinic; do not use imiquimod or podophyllotoxin in pregnancy. Vaginal, cervical, anal, or urethral warts → specialist gynaecology / colorectal / urology referral for clinic-based treatment. Large or refractory lesions → ablative treatment ± biopsy.
Fontos. Genital warts diagnosis warrants STI screening (HIV, syphilis, chlamydia, gonorrhoea, hepatitis B/C). HPV vaccination (Gardasil 9, available through public health programmes in many countries) reduces but does not eliminate recurrence risk and is not effective treatment for established warts. Cervical screening remains essential for women — high-risk HPV types (16, 18, others) cause cervical cancer; the wart-causing low-risk types (6, 11) do not. Persistent or atypical lesions warrant biopsy to exclude pre-malignant change. All MedsBase products ship from WHO-GMP tanúsítvánnyal rendelkező gyártóktól származik diszkrét csomagolásban történik, és a Újraküldési Garancia.